# Feasibility and Safety of Using Nasal High Flow Oxygen Postoperatively to Reduce Respiratory Complications

> **NCT04272268** · — · WITHDRAWN · sponsor: **University Hospitals of North Midlands NHS Trust**

## Conditions studied

- Cancer of the Esophagus

## Interventions

- **DEVICE:** Nasal High flow Oxygen

## Key facts

- **NCT ID:** NCT04272268
- **Lead sponsor:** University Hospitals of North Midlands NHS Trust
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** WITHDRAWN
- **Start date:** 2019-10-01
- **Primary completion:** 2020-03-31
- **Final completion:** 2020-03-31
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Covid-19
- **Last updated:** 2024-04-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04272268

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04272268, "Feasibility and Safety of Using Nasal High Flow Oxygen Postoperatively to Reduce Respiratory Complications". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04272268. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*